Clinical Study Results
The table below shows how many participants had adverse reactions.
Adverse reactions during this study
0.7 mg of AZD7594 1.6 mg of AZD7594 720 μg of AZD7594
through a nebulizer through a nebulizer through a DPI
(out of 24 (out of 24 (out of 24
participants) participants) participants)
How many
participants had 4.2% (1) 0.0% (0) 4.2% (1)
adverse reactions?
How many
participants had
0.0% (0) 0.0% (0) 0.0% (0)
serious adverse
reactions?
How many
participants left this
0.0% (0) 0.0% (0) 0.0% (0)
study due to adverse
reactions?
What adverse reactions happened during this study?
There were 2 adverse reactions that happened during this study:
• A reduced sense of taste. This happened in 4.2% of participants, which was 1 out
of 24 participants. This adverse reaction happened while this participant was taking
0.7 mg of AZD7594 through a nebulizer.
• Vertigo, which is a condition in which a person feels they are in motion even
though they are not. This happened in 4.2% of participants, which was 1 out of 24
participants. This adverse reaction happened while this participant was taking 720 μg
of AZD7594 through a DPI.
6